Axis Max Life CFO sees only transitory impact from IRDAI’s draft commission overhaul

Axis Max Life CFO believes the proposed commission overhaul will have only a transitory impact, as the life insurance industry adjusts to the new regulatory framework.

Axis Max Life: The Insurance Reporter

Axis Max Life expects the impact of IRDAI’s proposed commission reforms to be temporary, with the insurer seeing limited disruption to its business.

NEW DELHI – Axis Max Life Insurance expects only a transitory impact from the insurance regulator’s proposed overhaul of distribution commissions, its Chief Financial Officer Amrit Singh told CNBC-TV18. He also said Axis Bank remains keen to raise its stake by up to 10%, with the proposed reverse merger to follow.

The insurer’s cost structures with its banks and distribution partners are “quite okay”, Singh said. On that basis, he said, the company should be able to navigate the change at an overall level, and persistency in its renewal book should not be badly disrupted.

Axis Max Life: The backdrop

IRDAI released a consultation paper on September 24, 2026, proposing changes to insurance distribution economics, including potential cuts in commission rates. The draft norms also ban compulsory loan-insurance bundling, restrict employee incentives and introduce a three-tier distribution structure with clawback provisions to curb mis-selling.

NEWSLETTER

Enjoying this story?

Subscribe to our newsletter for fresh stories and expert insights delivered straight to your inbox.

PB Fintech, the parent of Policybazaar, closed down about 36% that day, its steepest single-day fall since listing. Max Financial Services, the listed parent of Axis Max Life, was among insurers that fell by as much as 12% intraday.

Also Read: Indiramma Insurance Scheme: ₹5 Lakh Cover for 1 Crore Families, Applications Begin Nov 19

Axis Max Life: Aggregator channel

Asked how business from PB Fintech and other third-party aggregators could be affected, Singh said the channel serves an important consumer need. It helps people discover prices, which keeps premiums in a healthy range. Axis Max Life has partnered with the platform for many years and is among its top partners.

The channel accounts for roughly 7-8% of the company’s business. The first year could see some impact, Singh said. But once first-year and renewal commissions are viewed together, the economics for distributors should be largely neutral. The focus on consumer-centric outcomes could further improve persistency, which he called already top-notch. He said the company does not expect a big disruption from the aggregator partner.

Analysts have flagged different exposure by line of business. Morgan Stanley said the net present value of PB Fintech’s health insurance business could fall 60-70% under the proposed framework, while the impact on its life insurance business could be relatively limited.

Axis Max Life: Is there a near-term dent?

Asked whether the final rules would need to be exactly as drafted for this view to hold, Singh said yes. On that basis, he said, about 97% of Axis Max Life’s business is largely fine. Only 2-3% could go through a transition, and even the 97% has a positive case for building momentum.

The interviewer noted that many in the industry hope the final rules will be watered down, and that distributors might delay hard choices until then. He asked whether the insurer could see a quarter or two of disruption from selling efforts.

Singh said a transitory effect was possible. With a new commission setup being introduced, some realignment will be needed. He said the task is not about reducing focus. It is about driving the penetration objective the regulator wants through more granular execution and greater effort.

The impact could shift by a quarter depending on the cut-off date, with some arriving early and some later, he said. It should normalise as the new commission structures take effect.

Axis Max Life: Axis Bank stake and reverse merger

Axis Bank remains interested in raising its stake in Axis Max Life by up to 10%, and discussions are continuing internally and with regulators. “We are aware of the fact that they’re very keen to increase the stake… up to 10%,” Singh said.

The proposed reverse merger process will follow the stake increase, he said, and is likely to move ahead in “months, rather than quarters”.

According to reports in July 2025, Axis Bank planned to buy an additional 10% in Axis Max Life through a preferential issue, which could bring in as much as ₹5,000 crore.

Follow us on Twitter for latest updates